Argipressin
CAS No. 113-79-1
Argipressin ( Vasopressin; Arg8-vasopressin; AVP )
产品货号. M20893 CAS No. 113-79-1
Argipressin is a peptide hormone with vasoconstrictive and antidiuretic activities that binds to the vascular arginine vasopressin receptor V1 with Kd values of 1.31 and 1.44 nM in A7r5 rat aortic smooth muscle cells and neonatal rat cardiomyocytes respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥470 | 有现货 |
|
5MG | ¥737 | 有现货 |
|
10MG | ¥972 | 有现货 |
|
25MG | ¥1288 | 有现货 |
|
50MG | ¥1531 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Argipressin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Argipressin is a peptide hormone with vasoconstrictive and antidiuretic activities that binds to the vascular arginine vasopressin receptor V1 with Kd values of 1.31 and 1.44 nM in A7r5 rat aortic smooth muscle cells and neonatal rat cardiomyocytes respectively.
-
产品描述Argipressin is a peptide hormone with vasoconstrictive and antidiuretic activities that binds to the vascular arginine vasopressin receptor V1 with Kd values of 1.31 and 1.44 nM in A7r5 rat aortic smooth muscle cells and neonatal rat cardiomyocytes respectively.
-
同义词Vasopressin; Arg8-vasopressin; AVP
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Others
-
适应症enuresis polyuria diabetes insipidus
化学信息
-
CAS Number113-79-1
-
分子量1084.23
-
分子式C46H65N15O12S2
-
纯度>98% (HPLC)
-
溶解度H2O:100 mg/mL (92.23 mM)
-
SMILESCC(=O)O.N=C(N)NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Byron K L . Vasopressin Stimulates Ca2+ Spiking Activity in A7r5 Vascular Smooth Muscle Cells via Activation of Phospholipase A2[J]. Circulation Research 1996 78(5):813-20.
产品手册
关联产品
-
Methyl 2,6-dihydroxy...
Methyl 2,6-dihydroxybenzoate is a natural product from Uvaria purpurea.
-
JNJ-26990990
JNJ-26990990 is a broad-spectrum anticonvulsant drug as a second-generation followup to the marketed drug topiramate.
-
Misonidazole
Misonidazole as a novel GPX inhibitors to cause oxidative stress in chemotherapy-resistant tumors.